| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −4.4× | −1.8× | |
| Price / Book | 0.8× | 2.1× | |
| Price / Sales | 1.8× | 4.0× | |
| Price / Free cash flow | −7.2× | −1.6× | |
| EV / EBITDA | −2.3× | −1.1× | |
| Earnings yield | −22.7% | −14.0% | |
| Free cash flow yield | −13.9% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LL |
| $1,260.07 |
| −3.57% |
| $1.19T |
| 59.6× |
| 77.8% |
| +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.47 | −1.55% | $634.25B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.63 | +0.15% | $504.74B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $417.80 | −1.69% | $375.02B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.69 | −1.73% | $356.98B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $149.52 | −4.32% | $269.43B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.89 | −0.98% | $265.03B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $671.28 | −0.78% | $248.2B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.23 | −1.58% | $238B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.64 | −0.35% | $194.23B | 22.9× | 37.5% | +26.7% |
